Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
The Heterogeneous Interplay Between Metabolism and Mitochondrial Activity in Colorectal Cancer
Christophe Desterke1, Yuanji Fu2, Jorge Mata-Garrido2
1Faculty of Medicine, University Paris Saclay, Institut National de la Santé et de la Recherche Médicale (INSERM) Unit UMRS-1310, 94800 Villejuif, France.
Colorectal cancer exhibits metabolic heterogeneity linked to mitochondrial activity. New R-packages reveal distinct metabolic profiles in tumor subtypes, aiding personalized cancer therapy development.
Area of Science:
- Oncology
- Metabolic Engineering
- Bioinformatics
Background:
- Colorectal cancer (CRC) is a heterogeneous malignancy influenced by genetic, environmental, nutritional, and lifestyle factors.
- CRC is often characterized by a Warburg metabolic phenotype, with increased glycolysis over oxidative phosphorylation.
- Understanding metabolic heterogeneity and mitochondrial activity is crucial for CRC research.
Purpose of the Study:
- To develop and utilize R-packages for exploring metabolic and mitochondrial activities in CRC transcriptomics data.
- To investigate the relationship between metabolic profiles, mitochondrial function, and CRC subtypes.
- To identify potential biomarkers for personalized therapeutic strategies in CRC.
Main Methods:
- Development of two R-packages, keggmetascore and mitoscore, for analyzing KEGG metabolism and Mitocarta V3 annotations.
- Application of packages to bulk and single-cell RNA-sequencing data from CRC samples.
- Utilized machine learning (Elastic-net) for predictive modeling and integrated multi-modal data analysis.
Main Results:
- Metformin stimulation regulated metabolism and mitochondrial activity in LOVO cells.
- Single-cell analysis revealed activated metabolism/mitochondria in MSI-high tumors and repressed in POLE-mutated tumors.
- Bulk analysis showed reduced metabolism/mitochondria in CRC vs. normal tissues; BRAF-V600E mutations correlated with repressed metabolism and fewer mitochondrial interactions.
- A novel metabolism/mitochondrial activity score predicted CMS1-MSI subtype, metastatic status, and BRAF-V600E mutation.
Conclusions:
- Mitochondrial metabolism plays a pivotal role in colorectal cancer subtyping.
- Metabolic and mitochondrial activity profiles serve as valuable predictive biomarkers for personalized CRC therapies.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Regulation of Metabolism
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondrial Membranes
Mitochondria

